Answer
Neutralising anti-erythropoietin antibody-mediated pure red cell aplasia has been reported with methoxy polyethylene glycol-epoetin beta, with frequency unknown; if diagnosed, treatment must be discontinued and patients should not be switched to another recombinant erythropoietic protein.
Sources for this answer
- Mircera solution for injection in pre-filled syringeRoche Products Limited · emc · SmPC §4.8 Undesirable effects · Version 27Document updated
Sources checked